Page last updated: 2024-10-22

anastrozole and Headache

anastrozole has been researched along with Headache in 3 studies

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Anastrozole was administered on cycle day 2 for the single-dose groups and on days 2-6 for the multiple-dose groups."2.71A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers. ( Buraglio, M; Denton, G; Hemsey, G; Tredway, DR, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tredway, DR1
Buraglio, M1
Hemsey, G1
Denton, G1
Buzdar, A1
Howell, A1

Reviews

1 review available for anastrozole and Headache

ArticleYear
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

    Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibit

2001

Trials

1 trial available for anastrozole and Headache

ArticleYear
A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers.
    Fertility and sterility, 2004, Volume: 82, Issue:6

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Sche

2004

Other Studies

1 other study available for anastrozole and Headache

ArticleYear
Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.
    The Medical letter on drugs and therapeutics, 2003, Mar-17, Volume: 45, Issue:1152

    Topics: Anastrozole; Asthenia; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; E

2003